Last update:

Oncology & Cancer news

Oncology & Cancer

Disrupting Asxl1 gene prevents T-cell exhaustion to improve immunotherapy, researchers discover

Immunotherapy, using a patient's own immune system to treat disease, has shown promise in some patients with cancer but has not worked in most. New research from St. Jude Children's Research Hospital and colleagues has found ...

Oncology & Cancer

Large-scale study identifies prostate cancer genetic risk factors in a diverse group of African men

Researchers have identified the genetic risk factors that contribute to prostate cancer in a diverse group of African men. Although research and treatment are scant, this first large-scale African genomics study could signal ...

Oncology & Cancer

Long-term study shows early prostate cancer surgery extended life

The survival rate of men with prostate cancer who had their entire prostate gland removed immediately after the tumor was detected increased by 17 percentage points compared with those who did not have treatment until the ...

Oncology & Cancer

Study uncovers mutations and DNA structures driving bladder cancer

How bladder cancer originates and progresses has been illuminated as never before in a study led by researchers at Weill Cornell Medicine and the New York Genome Center. The researchers found that antiviral enzymes that mutate ...

Oncology & Cancer

Do people with MS have an increased risk of cancer?

A study has found some cancers to be slightly more frequent in people with multiple sclerosis (MS) than in people without MS. The study is published in the October 9, 2024, online issue of Neurology. Types of cancers found ...

Oncology & Cancer

Rapid blood cancer diagnostic could speed decisions and save lives

Researchers at Dana-Farber Cancer Institute have created a CRISPR-based rapid molecular diagnostic for two forms of leukemia that are driven by mutations that involve gene fusions. The technology accurately detects the presence ...

Oncology & Cancer

New insights into glioblastoma treatment for elderly patients

A study led by Dr. Monika E. Hegi, MD, Ph.D. and European Organization for Research and Treatment of Cancer (EORTC) headquarters team (Felix Oppong Msc, Dr. Thierry Gorlia, Ph.D.) reveals that elderly glioblastoma patients ...

Oncology & Cancer

Big data and AI meet cancer research

Many cancer patients undergo treatment with multiple drugs, each of which attacks cancer in a different way, so the combination fights cancer on many fronts. But more drugs mean higher risks of side effects.

Medical research

Discovery of a protein controlling resistance to chemotherapy

Despite the recent development of new targeted therapies, chemotherapies remain the most frequently used treatment to treat patients suffering from advanced cancers. Chemotherapy resistance is one of the main causes of treatment ...

Oncology & Cancer

Brown fat may help improve cancer survival rates

Brown fat is not linked to cancer-associated loss of body weight and muscle mass, a common condition known as cachexia, according to a new joint study from The Rockefeller University and Memorial Sloan Kettering Cancer Center ...

Oncology & Cancer

Effective treatment in rare but deadly form of cancer

An advanced surgical therapy has proved considerably more efficacious than conventional treatments for patients with melanoma in the eye (uveal) that has spread to the liver, a University of Gothenburg study shows. The treatment ...

Oncology & Cancer

Dry shampoo and cancer risk: What you need to know

Many people use dry shampoo in their normal routine, stretching the days between washing their hair in the shower. In October of last year, the Food and Drug Administration found potentially elevated levels of benzene, a ...

Oncology & Cancer

Video: How is kidney cancer treated?

More than 50,000 people in the U.S. are diagnosed with kidney cancer each year. Risks factors for developing this type of cancer include environmental exposures, such as smoking, high blood pressure, a history of kidney failure, ...

Oncology & Cancer

Researchers identify key source of T cell 'exhaustion'

Custom-made to attack cancer cells, CAR T-cell therapies have opened a new era in the treatment of human cancers, particularly, in hematologic malignancies. All too often, however, they display a frustrating trait inherited ...

Oncology & Cancer

Can lymph nodes boost the success of cancer immunotherapy?

Cancer treatment routinely involves taking out lymph nodes near the tumor in case they contain metastatic cancer cells. But new findings from a clinical trial by researchers at UC San Francisco and Gladstone Institutes shows ...